Advanced Media, Inc.
3773・Growth Market・Information & Communication
Voice Business (Advanced Media, Inc. single segment)
A single-segment company leveraging AI speech recognition technology "AmiVoice®" as its core, deployed across healthcare, contact centers, and other fields
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue (consolidated, full year) | ¥7,063 million | ¥6,665 million | ↑ |
| Operating profit (consolidated, full year) | ¥1,440 million | ¥1,442 million | ↓ |
| Ordinary profit (consolidated, full year) | ¥1,558 million | ¥1,539 million | ↑ |
| Profit attributable to owners of parent (consolidated, full year) | ¥1,739 million | ¥1,408 million | ↑ |
| BSR1 stock revenue (full year) | ¥4,973 million | +12.2% year on year | ↑ |
| BSR1 stock ratio (fiscal year-end) | 80.0% | 74.6% | ↑ |
| Equity ratio (consolidated, fiscal year-end) | 84.2% | 77.1% | ↑ |
| Earnings per share (consolidated) | ¥111.18 | ¥90.40 | ↑ |
| Net assets per share (consolidated, fiscal year-end) | ¥895.02 | ¥788.93 | ↑ |
| Cash and cash equivalents (fiscal year-end balance) | ¥5,489 million | ¥4,105 million | ↑ |
Business Details
The Group develops its business through three formats—Service Business, Product Business, and Solution Business—centered on the AI speech recognition technology "AmiVoice®." It has a dual-axis structure consisting of its existing core business (BSR1: CTI, VoXT, Medical, and SDX divisions) and new businesses (BSR2: BDC headquarters, overseas business division, and consolidated subsidiaries), providing speech recognition solutions across a wide range of industries including contact centers, healthcare, legislative assemblies, construction, and manufacturing/logistics. Expansion of stock-type business (subscriptions/licenses) is positioned at the core of the growth strategy, with the BSR1 stock revenue ratio reaching 80.0% (+5.4pt year on year) in FY2026 (ending March 2026).
Recent Overview
Revenue and net profit reached record highs; decided to transition to IFRS and acquire feat Inc.
In FY2026 (ending March 2026), revenue reached ¥7,063 million (+6.0% year on year) and profit attributable to owners of parent reached ¥1,739 million (+23.5% year on year), both setting new record highs. Operating profit stood at ¥1,440 million, down 0.2% year on year, due to upfront investment in personnel and development, but ordinary profit reached a record high owing to increased interest income and expanded foreign exchange gains. The substantial increase in net profit was due to the recording of a gain on sale of investment securities of ¥997 million. The BSR1 stock ratio improved to 80.0% (+5.4pt year on year). The company will voluntarily adopt IFRS from FY2027 (ending March 2027), with earnings forecasts of revenue of ¥10,000 million and operating profit of ¥1,500 million (IFRS basis). As a subsequent event, on April 14, 2026, the company acquired all shares of feat Inc. (software testing and development), making it a consolidated subsidiary. In addition, the operating profit target for FY2027 (ending March 2027) was revised down from the previous ¥2.5 billion to ¥1.5 billion.
Key Products
Growth Drivers
- Continued adoption of AI speech recognition products and services against the backdrop of corporate needs for productivity improvement (strengthened integration with generative AI and AI agents)
- Expansion of subscription-type stock revenue across all BSR1 divisions (stock ratio of 80.0% at the end of FY2026 (ending March 2026), +5.4pt year on year)
- Expanding demand in the Medical division driven by "physician work-style reform" (cumulative license count rising from 64,775 to 68,991)
- Contribution to overall earnings improvement through revenue growth in BSR2 (overseas business division and BDC headquarters) (+19.5% year on year) and narrowing of losses
- Strengthened development capabilities and creation of composite solutions as a "voice AI enabler" through the acquisition of feat Inc. (April 2026)
- Enhanced international comparability of financial information and stronger appeal to capital markets through IFRS transition in FY2027 (ending March 2027)
- Development of the M-Dev strategy (sales channel expansion through partnerships with other companies) and the AISH (AI Super Humanization) market
Risks
- Increase in cost of revenue and SG&A expenses due to upfront investment in personnel recruitment and development (operating profit down 0.2% year on year in FY2026 (ending March 2026); operating profit target for FY2027 (ending March 2027) revised down from ¥2.5 billion to ¥1.5 billion)
- Risk of continued losses at BSR2 (overseas business division, AMIVOICE THAI, and Amisapo Co., Ltd.)
- Risk of intensifying competition and technological obsolescence amid rapid advances in AI speech recognition technology
- Over 90% of revenue depends on the domestic market, making it susceptible to domestic economic downturns and price increases
- Dependence on major customers (the overseas business division's performance is directly tied to the usage trends of major customers)
- Risk of fluctuations in reported results and transition costs due to changes in accounting treatment associated with the IFRS transition
- Risk of goodwill and integration costs arising from the acquisition of feat Inc. (details such as acquisition price undisclosed)
Last updated: June 24, 2026